Table 5.
Overall | First-line chemo | Second-line chemo | Third-line chemo | Fourth-line chemo | Phase 1 drug trial | Best supportive care | |
---|---|---|---|---|---|---|---|
Number of patients | 81 | 50 | 28 | 15 | 7 | 8 | 48 |
Overall survival in weeks (Range) | 38.7 (1–212) |
48.6 (3–200) |
43.0 (1–151) |
15.8 (5–100) |
13.6 (9–27) |
14.9 (1–46) |
3.4 (1–62) |